The Food and Drug Administration (FDA) last week approved Vraylar (cariprazine), a dopamine D2/D3 re...

The FDA has approved Invega Trinza (paliperidone palmitate), a long-acting atypical antipsychotic in...

Vyvanse—a medication approved in 2007 for attention-deficit/hyperactivity disorder (ADHD)—is the fir...

A new app will soon be available to help clinicians diagnose traumatic brain injury in as little as ...

Yesterday, the Food and Drug Administration approved Evzio, a naloxone hydrochloride auto-injector, ...

On Friday, the Food and Drug Administration (FDA) approved Vizamyl (flutemetamol) for use with posit...